Introduction
============

One of the most intrinsic immune defense mechanisms of multicellular organisms is to sacrifice infected cells for the benefit of the remaining cells. The major cell death modalities, including apoptotic cell death, necrotic cell death, and pyroptotic cell death, are critical defense mechanisms against microbial infection ([Fig. 1](#fig1){ref-type="fig"}; [@bib11]; [@bib55]; [@bib102]). For instance, in response to bacterial infection, programmed cell death, such as apoptosis, is induced as a host innate immune response. This cell death plays two defensive roles in infection. One is to eliminate pathogens at the early stage of infection without emitting alarm signals. The other role is to induce dendritic cells (DCs) to engulf apoptotic bodies containing infected microbes, which allows extracellular antigens to access MHC I molecules and subsequently induce a protective immune response ([@bib32]). Cell death can also benefit pathogens: one prominent strategy of many bacterial pathogens is to induce the demise of infected host cells, which allows the bacteria to efficiently exit the host cell, spread to neighboring cells, evade immune cells, and/or gain nutrients. Meanwhile, many bacterial pathogens, especially those capable of invading and multiplying within host cells, use multiple mechanisms to manipulate host cell death and survival pathways in order to maintain their replicative compartment ([@bib9]; [@bib49]; [@bib55]).

![**Bacteria-induced host cell death.** Bacteria induce host cell death through several distinct modalities, including apoptosis, necrosis, and pyroptosis. Apoptosis is a type of noninflammatory programmed cell death that is triggered by two different pathways, the intrinsic (mitochondria-mediated) pathway and extrinsic (receptor-mediated) pathway. Apoptosis is morphologically characterized by membrane blebbing, cell shrinkage, DNA fragmentation, mitochondrial permeability, and caspase (except for caspase-1) activation. In apoptosis, bacteria are retained within apoptotic bodies and engulfed by phagocytic cells. Necrosis is characterized by membrane rupture, nuclear swelling, and the release of cellular contents and is accompanied by caspase-independent inflammation. Necrosis is triggered by ROS production or danger signals, such as lysosomal destabilization, calpain release, and depletion of ATP, that are induced upon bacterial infection or physical damage. Pyroptosis is a type of programmed cell death that is coordinated by inflammasome-mediated caspase-1 activation and accompanied by membrane rupture, DNA fragmentation, and the release of pro-inflammatory cytokines, including IL-1β and IL-18. PAMPs and DAMPs are recognized by NLR proteins, which assemble the inflammasome to activate caspase-1and trigger pyroptosis.](JCB_201108081_RGB_Fig1){#fig1}

Professional phagocytes play pivotal roles in sensing bacteria through pathogen-associated molecular patterns (PAMPs) or danger-associated molecular patterns (DAMPs) by various pathogen recognition receptors (PRRs), including Toll-like receptors (TLRs), NOD-like receptors (NLRs), RIG-I--like receptors, C-type lectin receptors, and absence in melanoma 2 (AIM2)--like receptors ([@bib18]; [@bib24]). These sensors trigger innate immune responses and enhance antimicrobial defense responses. Phagocytes activated in response to infection efficiently phagocytose target microbes and transport them to lysosomes, where they are ultimately degraded. The phagocytes also emit various alarms to further amplify innate immune responses ([@bib69]). In addition to acting as front-line defense executioners, macrophages provide a safe niche for some bacterial pathogens, such as *Legionella pneumophila*, *Mycobacterium tuberculosis*, *Coxiella burnetii*, and *Brucella* spp. These bacteria have evolved mechanisms to manipulate host membrane trafficking, remodel bacteria-containing vacuoles, modulate cell death signaling, and prolong the longevity of the replicative compartment so they can survive and multiply therein ([@bib53]; [@bib9]). Non-professional phagocytic cells such as epithelial cells also act as front-line defense executioners against microbial intrusion by using various PRRs to recognize PAMPs and DAMPs. Epithelial cells that sense microbial infection trigger oxidative stress, ER stress, mitochondrial stress, DNA stress, inflammatory responses, and autophagy, subsequently activate various antimicrobial defense systems including cell death and cell exfoliation ([@bib55]; [@bib102]). In addition, many epithelial cells, such as gut epithelial cells, are exploited as an infectious foothold by various gastrointestinal pathogens such as enteropathogenic *E. coli* (EPEC), enterohemorrhagic *E. coli* (EHEC), *Salmonella* Typhimurium, *Yersinia*, *Shigella flexneri*, and *Helicobacter pylori*. These pathogenic bacteria have highly evolved mechanisms to manipulate the host cell membrane architecture, cell--cell junctions, cytoskeletal dynamics, membrane trafficking, cell cycle progression, and cell death signaling to promote bacterial colonization of the gut epithelium ([@bib78]; [@bib49]).

Although the mechanisms whereby bacterial pathogens manipulate the host cell death pathway vary among different pathogens and host cell types, the following three pathways are widely used as targets for bacterial pathogens to enhance pathogenesis: the mitochondria-dependent pro-death pathway, NF-κB--dependent pro-survival pathway, and inflammasome-dependent cell death pathway ([@bib11]; [@bib55]; [@bib81]). In this review, we highlight some selected examples of the strategies that are used by human bacterial pathogens to manipulate these host cell pathways during infection ([Table I](#tbl1){ref-type="table"}).

###### 

Selected examples of bacterial pathogens and host cell death

  Bacteria                       Factor            Function                                Mechanism                                                                                                 Host target                          Reference
  ------------------------------ ----------------- --------------------------------------- --------------------------------------------------------------------------------------------------------- ------------------------------------ ---------------------------------------------------
  *Chlamydia trachomatis*        CPAF              Inhibition of apoptosis                 Degradation of proapoptotic proteins                                                                      BH3-only proteins                    [@bib76]
                                 Unknown           Inhibition of apoptosis                 Leads to mislocalizaton and prevents proapoptotic activity                                                Bad                                  [@bib94]
  EPEC                           NleH              Inhibition of apoptosis                 Inhibits caspase-3 activation                                                                             BI-1                                 [@bib42]
                                 NleD              Inhibition of apoptosis                 Cleaves JNK via metalloprotease activity and inhibits JNK signaling                                       JNK                                  [@bib8]
  *Helicobacter pylori*          CagA              Inhibition of apoptosis                 Up-regulation of anti-proapoptotic protein, Mcl-1                                                         MCL-1                                [@bib67]
                                 Unknown           Inhibition of apoptosis                 Activates EGFR--Akt--Bcl2 antiapoptotic pathway                                                           EGFR                                 [@bib99]
  *Legionella pneumophila*       SdhA              Inhibition of cell death                Inhibits mitochondrial disruption and caspase activation                                                  Unknown                              [@bib54]
                                 SidF              Inhibition of apoptosis                 Inhibits apoptosis signaling                                                                              BNIP3, Bcl-rambo                     [@bib6]
                                 LegK1             Inhibition of cell death?               Promotes host pro-survival signal via NF-κB activation                                                    IκBα, p100                           [@bib40]
                                 LnaB              Inhibition of cell death?               Promotes host pro-survival signal via NF-κB activation                                                    Unknown                              [@bib58]
                                 Flagellin         Induction of pyroptosis                 Induces the NAIP5--NLRC4--inflammasome--caspase-1 activation                                              NLRC4, NAIP5                         [@bib3]; [@bib79]; [@bib51]; [@bib101]
  *Mycobacterium tuberculosis*   Unknown           Inhibition of apoptosis                 Up-regulation of anti-proapoptotic proteins, Mcl-1 and A1                                                 MCL-1, A1                            [@bib86]; [@bib56]; [@bib27]
                                 Zmp1              Inhibition of inflammasome activation   Inhibits caspase-1 activation and IL-1β secretion                                                         Unknown                              [@bib61]
  *Salmonella* Typhimurium       Flagellin, PrgJ   Induction of pyroptosis                 Induces the NAIP--NLRC4--inflammasome--caspase-1 activation                                               NLRC4, NAIP2, NAIP5                  [@bib39]; [@bib62], [@bib64]; [@bib51]; [@bib101]
                                 AvrA              Inhibition of apoptosis                 Modifies acetyltransferase activity toward MAPKK and inhibits JNK activation                              MAPKKs                               [@bib45]
                                 SopB              Inhibition of apoptosis                 Induction of host pro-survival activity                                                                   PI3K/Akt                             [@bib50]; [@bib52]
  *Shigella flexneri*            Unknown           Induction of necrotic cell death        Induces mitochondrial dysfunction                                                                         BNIP3, CypD                          [@bib17]
                                 Unknown           Inhibit mitochondrial dysfunction       Activates Nod1--RIP2--NF-κB pro-survival signaling                                                        Bcl2                                 [@bib17]
                                 MxiI              Induction of pyroptosis                 Induces the NLRC4--inflammasome--caspase-1 activation                                                     NLRC4                                [@bib88]; [@bib64]
  *Yersinia*                     YopJ              Induction of apoptosis                  Inhibition of NF-κB and MAPK signaling via acetyltransferase activity results in induction of apoptosis   MAPKKs, IKKβ                         [@bib68], [@bib74]; [@bib70]
                                 YopK              Inhibition of pyroptosis                Prevents inflammasome recognition by interacting with T3SS translocon                                     T3SS translocon (bacterial target)   [@bib14]; [@bib26]

The mitochondria-dependent cell death pathway
=============================================

Apoptosis is a major cellular defense response during pathogen infection, and the mitochondria play a central role in modulating the host cell death and survival pathways ([@bib81]). Apoptosis is triggered by two different pathways: the extrinsic pathway and the intrinsic pathway. The extrinsic pathway is activated upon stimulation of the transmembrane death receptors, including FasL, TNF-R1, and Apo2/Apo3. These receptors transmit external apoptotic signaling to the death machinery, which results in the activation of the executioners caspase-3 and -7. The intrinsic pathway is initiated through the release of signaling factors from the mitochondria. Various intrinsic stimuli activate Bcl-2 homology 3 (BH3)--only proteins, which overcome the inhibitory effects of anti-apoptotic Bcl-2 proteins. The activated BH3-only proteins promote the oligomerization of pro-apoptotic proteins, such as Bax and Bak, in the mitochondrial outer membrane, which results in the release of cytochrome *c* into the cytoplasm. Cytochrome *c* stimulates formation of the apoptosome, a multimeric protein complex that serves as a scaffold for the caspase activation, which proteolytically activates procaspase-9. Caspase-9 then cleaves and activates other caspases that cleave numerous substrates to ultimately induce apoptosis ([Fig. 1](#fig1){ref-type="fig"}; [@bib5]). Blocking or delaying cell death is a prominent strategy used by pathogens to promote intracellular survival and replication ([@bib5]; [@bib81]).

Manipulation of the mitochondrial cell death pathway by intracellular pathogens.
--------------------------------------------------------------------------------

*L. pneumophila* replicates within alveolar macrophages, during which the pathogen postpones host cell death by delivering a subset of effectors, including SdhA and SidF, via a type IV secretion system (T4SS; [Fig. 2](#fig2){ref-type="fig"}). The mechanism by which SdhA inhibits macrophage cell death remains unclear ([@bib54]). SidF targets two pro-apoptotic factors, BNIP3 and Bcl-rambo, thereby inhibiting mitochondria-mediated apoptotic signaling ([@bib6]). Indeed, macrophages infected with a *L. pneumophila sdhA* or *sidF* mutant undergo more apoptosis and have reduced bacterial replication than macrophages infected with wild-type *Legionella*, suggesting that blocking the macrophage apoptotic response is important for *Legionella* pathogenesis.

*Chlamydia* spp. use multiple mechanisms to prevent premature host cell death that involve bacterial factors that likely interact with mitochondrial components involved in apoptotic cell death ([Fig. 2](#fig2){ref-type="fig"}; [@bib34]; [@bib37]; [@bib28]; [@bib100]). *Chlamydia trachomatis* inhibits apoptosis by degrading pro-apoptotic BH3-only proteins, including Bim, Puma, and Bad ([@bib37]; [@bib28]; [@bib100]), and this degradation is partially mediated by *Chlamydia*-secreted chlamydial protease-like activity factor (CPAF; [@bib76]). Furthermore, *Chlamydia* infection activates phosphoinositide-3 kinase (PI3K), which leads to Akt activation and subsequent phosphorylation of the pro-apoptotic protein, Bad ([@bib94]). Phosphorylated Bad can interact and colocalize with 14-3-3β on the *Chlamydia* inclusion vacuole through an interaction between IncG, a bacterial-encoded inclusion protein, and 14-3-3β ([@bib85]). These interactions sequester Bad from the mitochondria, thus allowing the pathogen to prevent host cell apoptosis ([Fig. 2](#fig2){ref-type="fig"}; [@bib94]).

![**Bacterial manipulation of mitochondrial cell death pathways.** *Legionella* deliver SidF and SdhA. SidF interacts with two pro-apoptotic proteins, BNIP3 and Bcl-rambo, and inhibits apoptotic signaling. SdhA inhibits host cell death and enhances bacterial survival and replication by an as yet unknown mechanism. *A. phagocytophilum* delivers Ats-1 and prevents the loss of mitochondrial membrane potential (MMP) and Bax translocation to the mitochondria to inhibit apoptosis. EPEC delivers NleH, which interacts with Bax inhibitor 1 (BI-1) and blocks epithelial apoptosis. *Chlamydia* secrete CPAF, which degrades the pro-apoptotic BH3-only proteins, thereby blocking the release of cytochrome *c* from the mitochondria. *Chlamydia* infection also inhibits the function of the pro-apoptotic protein Bad by causing its phosphorylation by Akt and mislocalization to *Chlamydia* inclusion vacuoles via its interaction with 14-3-3β and IncG. *H. pylori* delivers the T4SS effector CagA to attenuate epithelial cell apoptosis. The CagA and Grb2 or Crk interaction stimulates the ERK1/2 pathway and up-regulates the production of the anti-apoptotic factor MCL-1. *H. pylori* activates EGFR, thereby up-regulating anti-apoptotic signaling involving Akt and Bcl2.](JCB_201108081_RGB_Fig2){#fig2}

*Anaplasma phagocytophilum*, the causative agent of human granulocytic anaplasmosis, infects neutrophils and prevents their apoptosis by inhibiting the decrease in the anti-apoptotic protein Bfl1 and the loss of mitochondrial membrane potential ([@bib41]; [@bib80]). A recent study determined that the *Anaplasma* T4SS effector Ats-1, which contains an N-terminal mitochondria-targeting sequence, can target the mitochondria ([@bib72]). [@bib72] showed that Ats-1 can prevent Bax from relocalizing from the cytoplasm into the mitochondria and inhibit cytochrome *c* release in neutrophils, suggesting that *Anaplasma* has evolved strategies to survive within neutrophils ([Fig. 2](#fig2){ref-type="fig"}).

These studies suggest that the demise of infected cells is an important host innate defense mechanism, and that bacteria counteract these host cell death responses during the early stage of infection to facilitate their intracellular replication.

Modulation of the mitochondrial cell death pathway by enteric pathogens.
------------------------------------------------------------------------

Some gastrointestinal bacterial pathogens use countermeasures against the rapid epithelial cell death response by interfering with the mitochondria-dependent cell death pathway (and enhancing the NF-κB pro-survival pathway). EPEC, EHEC, and *Citrobacter rodentium* use a type III secretion system (T3SS) to deliver a subset of effectors into the intestinal epithelium. One of these effectors, EspF, has multiple functions that manipulate a variety of host signaling pathways that are involved in cytoskeletal rearrangement, disruption of cell--cell junctions, epithelial cell death, and immune modulation ([@bib43]). EspF, which contains an N-terminal mitochondrial targeting sequence, targets the mitochondria and stimulates cell death by disrupting the mitochondrial membrane potential ([@bib73]; [@bib71]). These EspF-dependent cellular responses appear to benefit pathogenesis because mice infected with a *C. rodentium espF* mutant have reduced lethality, intestinal hyperplasia, and bacterial loads in the intestine ([@bib25]; [@bib71]). Earlier studies showed that EPEC-infected epithelial cells expressed phosphatidylserine on their surface and had DNA fragmentation, but showed no signs of cell shrinkage, membrane blebbing, or nuclear condensation, which are characteristic of late-stage apoptotic cell death ([@bib21], [@bib22]). Thus, these findings indicate that EPEC can inhibit the host cell death response despite initially triggering it through EspF. A recent study provided insight into the mechanisms by which EPEC inhibits early apoptosis. The EPEC NleH effector targets the ER six-transmembrane protein Bax inhibitor-1 (BI-1) to prevent elevated cytoplasmic Ca^2+^ levels, nuclear condensation, caspase-3 activation, and membrane blebbing of infected epithelial cells ([@bib42]). Infection of BI-1 knockdown cells with the EPEC-related mouse pathogen, *C. rodentium*, resulted in the loss of NleH-dependent anti-apoptotic activity, and mice infected with a *C. rodentium nleH* mutant exhibited increased caspase-3 cleavage in the intestinal epithelium compared with mice infected with wild-type *C. rodentium* ([@bib42]). Thus, NleH may promote colonization by slowing down enterocyte loss from the intestine.

*H. pylori* can manipulate the gastric epithelial mitochondria-dependent and -independent cell death pathways to promote persistent colonization of the stomach mucosa ([@bib38]). *H. pylori* feeds on nutrients in the mucin layer and exudates from epithelial cells that are damaged as a result of gastric inflammation, reactive oxygen species (ROS), apoptosis, and compromised cell--cell junctions ([@bib38]). *H. pylori* delivers CagA, a major virulence factor, via a T4SS into the gastric epithelium. CagA has multiple activities that usurp signaling pathways involved in gastric epithelial cell proliferation, cell death, cell--cell junctions, cell scattering, inflammatory responses, and gene regulation, all of which contribute to bacterial colonization and gastritis ([@bib38]). For instance, CagA interacts with many cellular proteins that activate a variety of transcriptional factors such as NF-κB, nuclear factor of activated T cells (NFAT), serum response factor (SRF), and T cell factor/lymphoid enhancer factor (TCF/LEF; [@bib4]; [@bib97]). CagA is also responsible for dampening apoptosis of matured gastric epithelial cells ([@bib67]). When etoposide, an apoptosis inducer, was orally administered to Mongolian gerbils to induce intrinsic apoptotic cell death, *H. pylori* infection of the stomach up-regulated the production of ERK, a pro-survival factor, and Mcl-1, an anti-apoptotic factor, in a CagA-dependent manner, which promoted *H. pylori* colonization of the gerbil stomach ([@bib67]). [@bib99] infected wild-type and kinase-defective epidermal growth factor receptor (EGFR) mice with *H. pylori* and demonstrated that *H. pylori*--induced EGFR phosphorylation stimulated PI3K-dependent activation of the anti-apoptotic factor Akt, increased expression of the anti-apoptotic factor Bcl-2, and decreased expression of the pro-apoptotic factor Bax, suggesting that *H. pylori* uses multiple mechanisms to suppress gastric epithelial cell death and promote infection ([Fig. 2](#fig2){ref-type="fig"}).

Mitochondria-dependent cell death pathways in bacteria--host interactions have been extensively documented and are well recognized as major pathogenic strategies for many bacterial pathogens ([@bib12]; [@bib55]). However, the underlying molecular mechanisms of cell death that result from interactions between bacterial factors and host factors as well as the biological significance of these interactions in vivo are still unknown. Further studies using animal models will be important to evaluate the impact of mitochondria-dependent and -independent cell death responses on bacterial pathogenesis and disease progression.

Manipulation of the NF-κB pro-survival pathway by bacterial pathogens
=====================================================================

NF-κB is one of the master regulators of the innate immune response and it functions by activating the host inflammatory signaling pathway and cell survival pathway. For example, NF-κB has been shown to protect against TNF-R1--induced cell death by up-regulating NF-κB--targeted genes, such as A20, FHC, Mn-SOD, XIAP, and Gadd45b. These genes suppress signaling events downstream of TNF-R1 activation, which are ROS production, MAP kinase kinase (MAPKK) activation, and induction of the Jun--N-terminal kinase (JNK) cascade ([@bib16]). Many bacterial pathogens use a variety of mechanisms to manipulate the NF-κB--regulated survival pathway in order to modulate the host cell death response and thus promote intracellular replication and pathogenicity.

*L. pneumophila* delivers T4SS effectors to manipulate the NF-κB pro-survival pathway and delay macrophage cell death ([Fig. 3](#fig3){ref-type="fig"}; [@bib57]; [@bib2]; [@bib7]). The *L. pneumophila* effector LegK1 phosphorylates and inactivates IκBα and p100, inhibitor proteins of NF-κB, thus enhancing the activation of the NF-κB pro-survival pathway ([@bib40]). *Legionella* also deliver the LnaB effector to activate NF-κB. Although the functions of LnaB are still unclear, introduction of LnaB and an NF-κB reporter into HEK293T cells showed that LnaB enhanced NF-κB activity compared with the mock control. In addition, macrophages that are infected with a *L. pneumophila lnaB* mutant had reduced NF-κB activity ([@bib58]). Despite this evidence showing the enhancement of the NF-κB--dependent pro-survival pathway by these effectors, additional in vivo studies are required because *L. pneumophila* lacking either LegK1 or LnaB did not show a significant replication defect in macrophages ([@bib58]).

![**Bacterial manipulation of host pro-survival pathway.** *M. tuberculosis* activates host anti-apoptotic signaling by up-regulating the anti-apoptosis genes *Mcl-1*, *bfl1*, and *FLIP*. NuoG dampens Nox2-mediated host signaling, resulting in the inhibition of apoptosis. *Legionella* deliver LegK1 and LnaB, which enhance the pro-survival activity of NF-κB. *Shigella* invasion of the epithelium results in mitochondria permeability transition (MPT)−dependent ROS production and necrosis-like cell death, which is counterbalanced by the NOD1−RIP2−NF-κB−Bcl2 pro-survival pathway. PGN, peptidoglycan. *Salmonella* deliver SopB and AvrA via the T3SS, and they inhibit apoptosis by activating the PI3K--Akt pro-survival pathway via inositol phosphate activity and by preventing JNK pro-cell death signaling via acetyltransferase activity, respectively. EPEC also targets JNK signaling by delivering NleD, which uses its metalloprotease activity to cleave JNK, thereby inhibiting cell death.](JCB_201108081_RGB_Fig3){#fig3}

*M. tuberculosis* uses two distinctive strategies during macrophage infection to control cell death; the pathogen postpones cell death early during infection, but induces cell death in the later stage of infection to promote bacterial egress from infected macrophages. Studies with monocyte-derived THP-1 cells showed that *M. tuberculosis* infection up-regulates TLR2/NF-κB signaling, which results in the up-regulation of FLIP, a powerful inhibitor of death receptor signaling ([@bib56]). A search for anti-apoptosis--related genes in the *M. tuberculosis* genome led to the identification of the *nuoG* gene, which encodes the NuoG subunit of the type I NADH-hydrogenase, NDH-1, and can neutralize the NOX-2--mediated increase in phagosomal ROS and TNF production and thus inhibit apoptosis ([Fig. 3](#fig3){ref-type="fig"}; [@bib93]; [@bib66]). A *M. tuberculosis nuoG* mutant decreased the ability to inhibit macrophage apoptosis and significantly reduced virulence in mice ([@bib93]). The apoptotic phenotype of the *nuoG* mutant was significantly reduced in human macrophages treated with a TNF-neutralizing antibody as well as in *TNF*^−/−^ murine macrophages ([@bib66]). The bacterial pathogenic strategy to counteract host cell apoptosis was also verified by infecting either macrophages with reduced *Mcl-1* expression (by siRNA knockdown) or *bfl1* knockout mice. Both of these models exhibited decreased mycobacterial pathogenesis ([@bib86]; [@bib27]). Recent studies reported that *M. tuberculosis* uses a different strategy at the late stage of infection in order to augment macrophage cell death and facilitate the egress of intracellular bacteria and further infection of other cells via a yet-uncharacterized caspase-independent pathway that shares features of necrosis ([@bib9]).

*Salmonella* infect the intestinal mucosa using two distinctive pathways, the *Salmonella* pathogenicity island 1 (SPI-1)--dependent pathway and SPI-2--dependent pathway. *Salmonella* infection of the gut triggers inflammation due to the delivery of effectors via the T3SS-1 and T3SS-2 encoded by SPI-1 and SPI-2, respectively ([@bib46]). In the SPI-1 pathway, *Salmonella* directly invades the intestinal epithelium by delivering the SopB, SopE, SopE2, and SipA effectors via the T3SS-1, in which bacterial invasion results in acute inflammatory responses. In the SPI-2 pathway, *Salmonella* is apprehended by intestinal DCs, which extend dendrites between epithelial cells to directly engulf luminal bacteria ([@bib92]; [@bib46]). Once *Salmonella* cross the epithelium, the bacteria encounter DCs, macrophages, B cells, and T cells, and some bacteria gain further access to the host circulation within CD18^+^ cells, which ultimately allows the bacteria to access the mesenteric lymph nodes, spleen, and liver ([@bib92]). An early report with human intestinal epithelial cells indicated that TNF and nitric oxide production, which is induced upon bacterial infection, leads to a delayed apoptosis ([@bib48]). Subsequent studies indicated that infection of human intestinal epithelial cells with *S*. Dublin or the porcine intestine with *S*. Typhimurium induced caspase-3--dependent and --independent cell death, but only after prolonged exposure to the pathogens, implying that the pathogen is capable of suppressing cell death at the initial stage of infection ([@bib75]; [@bib83]). Recent studies showed that the *Salmonella* AvrA and SopB effectors modulate both inflammatory and cell death responses ([Fig. 3](#fig3){ref-type="fig"}). AvrA possesses acetyltransferase activity for MAPKKs and strongly inhibits the JNK signaling pathway, which helps dampen inflammatory and cell death responses ([@bib45]; [@bib29]). Likewise, the EPEC NleD effector was shown to target the JNK signaling pathway to inhibit apoptosis. NleD uses its zinc metalloprotease activity to cleave JNK (and p38), and thus blocks the JNK-mediated pro-apoptotic pathway ([Fig. 3](#fig3){ref-type="fig"}; [@bib8]). SopB protects epithelial cells from apoptosis by maintaining the activation of Akt, an anti-apoptosis factor ([@bib50]). The ability of SopB to antagonize apoptosis appears to be dependent on its inositol phosphatase activity, which likely directly up-regulates Akt activity. The protective role of Akt2, an isoform of Akt, in *Salmonella*-induced gastroenterocolitis was recently verified using *Akt2* knockout mice; *Salmonella*-infected *Akt2*^−/−^ mice showed enhanced morbidity and mortality that was associated with increased bacterial loads in the intestine and elevated levels of proinflammatory cytokines (TNF, IFN-γ, and MCP-1), which are associated with increased apoptosis, compared with wild-type mice ([@bib52]).

*Shigella* induce both necrosis-like and apoptosis-like cell death in a caspase-1-independent manner upon infection of epithelial cells ([@bib19]; [@bib17]; [@bib33]). However, the bacteria further manipulate the host cell survival pathway by dampening cell death signals until the late stages of infection when the bacteria have fully replicated and spread among epithelial cells. *Shigella* can dampen the mitochondrial dysfunction--mediated necrotic-like cell death response by activating the Nod1--RIP2--NF-κB--Bcl-2 pro-survival pathway ([Fig. 3](#fig3){ref-type="fig"}; [@bib17]). Consistent with this model, *Nod1*^−/−^ MEFs or NF-κB inhibitor--treated epithelial cells infected with *Shigella* have a rapid loss of mitochondria permeability transition and ROS production, leading to necrotic-like cell death ([@bib17]). Cell death signaling in response to *Shigella* infection becomes predominant in the later stages of infection, and this process depends on the BH-3--only protein BNIP3 and cyclophilin D (CypD) in mitochondrial permeability and the transition to cell death. A kinetic study supports the premise that cytoprotective signaling is dominant during early bacterial replication within epithelial cells but is overwhelmed by cell death signaling at a later stage, thereby allowing the bacteria to egress and transit toward the lumen ([@bib17]).

As discussed here, establishing a protective or replicative niche during infection is an essential pathogenic mechanism, while the demise of infected cells is an important host defense mechanism that clears the bacteria and sends alarms that activate the host immune system. In addition, the gut epithelium undergoes rapid turnover that is sustained by a balance between cell proliferation and death, and cell death plays a critical role in maintaining this tissue homeostasis. Therefore, the most simple and efficient means for bacterial pathogens to prolong cell viability, such as manipulation of NF-κB pro-survival signaling, and thus promote bacterial growth, would be a "gain in time strategy" ([@bib49]).

Inflammasome activation through recognition of bacterial infection
==================================================================

Bacterial pathogens deliver cytotoxins and T3SS effectors (as well as T3SS components and flagellin) to the host cell membrane and cytoplasm to modify the host cell surface architecture, induce membrane damage, subvert cell signaling, and modulate cell physiology in order to promote infection. Thus, bacteria can activate the innate immune system when PAMPs and DAMPs in an atypical cellular location are recognized by cytoplasmic PRRs such as NLRs. Upon recognition of DAMPs and PAMPs, NLRs induce the assembly of the inflammasome, which is composed of NLR, ASC, and caspase-1, to drive the proximity-induced activation of caspase-1, which results in the extracellular release of IL-1β and IL-18 and induces pyroptosis. Pyroptosis is a type of inflammatory programmed cell death that is coordinated by inflammasome-mediated caspase-1 activation ([Fig. 1](#fig1){ref-type="fig"}; [@bib10]; [@bib84]; [@bib24]). For example, NLRP3 senses damaged cell membranes, infection by *Listeria monocytogenes*, *Shigella*, *S.* Typhimurium, *Staphylococcus aureus*, *Neisseria gonorrhoeae*, and *Chlamydia spp*, as well as bacterial pore-forming toxins ([@bib60]; [@bib98]; [@bib1]; [@bib31]; [@bib15]; [@bib47]). NLRC4 detects bacterial infection with *L. monocytogenes* and *S.* Typhimurium ([@bib60]; [@bib95]; [@bib15]). In addition, NLRC4 can sense flagellin and the T3SS rod components of *S.* Typhimurium, *L. pneumophila*, *Pseudomonas aeruginosa*, and *Shigella* ([@bib59]; [@bib3]; [@bib39]; [@bib62], [@bib63], [@bib64]; [@bib87]; [@bib88]). Recent reports show that NAIP (NLR family, apoptosis inhibitory protein) family members act as pathogen sensors that determine the specificity of NLRC4 inflammasome for different bacterial ligands. In fact, NAIP5 specifically activates NLRC4 inflammasome in response to flagellin, whereas NAIP2 is required for inflammasome activation by T3SS rod components ([@bib79]; [@bib51]; [@bib101]). NLRP1b recognizes *Bacillus anthracis* lethal toxin, a major virulence factor from *B. anthracis*. Indeed, mutations in the *Nlrp1b* gene were identified as the susceptibility locus for anthrax lethal toxin-induced macrophage cell death in mice ([@bib13]). AIM2 binds to dsDNA via its C-terminal HIN200 domain, and responds to *Francisella tularensis* and *L. monocytogenes* infection in murine macrophages when these bacteria undergo spontaneous autolysis, resulting in caspase-1 activation and pyroptosis ([@bib35]; [@bib44]; [@bib77]; [@bib82]; [@bib90]; [@bib96]). These studies indicate that NLR inflammasomes play a key role in host innate defense against a variety of microbes and in maintaining tissue homeostasis.

Modulation of inflammasome activation by bacterial pathogens.
-------------------------------------------------------------

Some bacterial pathogens use distinctive strategies to modulate inflammasome-dependent cell death, which is an important pathogenic mechanism to avoid host cell death and the release of inflammatory intracellular contents during infection ([@bib36]). For example, *S.* Typhimurium evades recognition of NLRC4 by repressing the expression of PrgJ, a T3SS-1 rod component, and flagellin after phagocytosis, whereby instead expressing T3SS-2, which is not detected by NLRC4 ([@bib23]; [@bib62], [@bib64]). Indeed, when macrophages are infected with a *S*. Typhimurium strain that constitutively expresses flagellin, the bacteria are efficiently eliminated ([@bib65]). *Salmonella* replicate within macrophages, and during this period the pathogen gradually switches from SPI-1 to SPI-2 expression. This change in SPI expression appears to allow the bacteria to efficiently evade NLRC4--inflammasome activation, thereby promoting bacterial replication and facilitating further infection.

*Yersinia* use strategies that both inhibit and induce cell death during infection of macrophages. Some of the Yop effectors delivered via the T3SS play key roles in modulating host innate and adaptive immune responses ([@bib30]). When *Yersinia* infect naive macrophages, the LPS that is released from the bacteria is recognized as a PAMP, which rapidly activates NF-κB-- and MAPK-dependent pro-survival pathways. However, these signaling pathways are abrogated in the early stage of infection. One Yop effector, YopJ, interferes with these signaling pathways, allowing *Yersinia* to enhance apoptosis ([Fig. 4](#fig4){ref-type="fig"}; [@bib68]). YopJ possesses unique acetyltransferase activity that acetylates the serine and threonine residues in host kinases, including the MAPKKs and the IκB kinase complex (IKKβ). YopJ targeting of these kinases can inhibit their activity ([@bib74]; [@bib70]), allowing *Yersinia* to block pro-survival signaling in the initial stage of infection in naive macrophages, which instead leads to apoptosis. Apoptosis in the initial stage of infection by *Yersinia* is likely to benefit pathogens because the pathogens can kill macrophages without inflammatory responses. Nevertheless, macrophage activation followed by continuous *Yersinia* infection can gradually redirect the initial YopJ-dependent apoptosis to YopJ-independent, caspase-1--mediated pyroptosis ([@bib10]). It seems that redirection to pyroptosis in activated macrophages is the host defense strategy for bacterial clearance. To evade macrophage-directed defensive actions, *Yersinia* deliver the T3SS YopK effector to inhibit inflammasome activation and prevent pyroptosis ([Fig. 4](#fig4){ref-type="fig"}; [@bib14]). Interestingly, YopK can interact with the T3SS translocon and interfere with T3SS recognition by NLRP3 and NLRC4, allowing the bacteria to evade IL-1β secretion and pyroptosis ([@bib14]). A more recent study shows that YopK regulates effector translocation through the T3SS from inside the host cells, thereby preventing pyroptosis ([@bib26]). When bone marrow--derived macrophages are infected with a *Y. pseudotuberculosis yopK* mutant, NLRP3 inflammasome activation and cell death increase and the bacterial load decreases compared with infection with wild-type *Yersinia*. *Casp1*^−/−^ mice infected with YopK-positive or -negative mutant have similar bacterial loads ([@bib14]), indicating that caspase-1--dependent responses against *Yersinia* are critical for bacterial clearance.

![**Bacterial manipulation of inflammasome activation.** PAMPs or DAMPs (such as dsDNA) generated by bacterial invasion and multiplication in macrophages trigger NLRP3-, NLRC4-, AIM2-inflammasome assembly and induce pyroptosis. *Yersinia* induce apoptosis by YopJ-mediated inhibition of pro-inflammatory signaling in the initial stage of infection in naive macrophages. Activated macrophages redirect YopJ-mediated apoptosis to YopJ-independent pyroptosis. However, *Yersinia* prevent inflammasome activation by secreting YopK, which interferes with T3SS recognition by NLRP3 and NLRC4. *M. tuberculosis* Zmp1, a Zn metalloprotease, and *F. tularensis* MviN, a putative lipid II flippase, prevent inflammasome activation and IL-1β secretion/pyroptosis by unknown mechanisms.](JCB_201108081_RGB_Fig4){#fig4}

*M. tuberculosis* inhibits inflammasome activation by secreting the zinc metalloprotease Zmp1 ([Fig. 4](#fig4){ref-type="fig"}). [@bib61] identified Zmp1 as a mycobacterial virulence factor using a mouse infection model as well as murine and human macrophages. The *Mycobacteria zmp1* mutant failed to prevent mycobacteria-containing phagosome maturation and caspase-1 activation, which are required to clear mycobacteria from infected macrophages and from mouse lungs infected via aerosol administration. However, the *zmp1* mutant was not cleared from murine macrophages when either inflammasome component expression, such as NLRC4, ASC, or caspase-1, was knocked down using siRNA ([@bib61]). Although it is still unclear how Zmp1 antagonizes inflammasome activation, the discovery of Zmp1 underscores the important role of inflammasome-mediated IL-1β production in mycobacterial clearance.

*F. tularensis,* a facultative intracellular zoonotic pathogen, is phagocytosed by macrophages, and the phagosomes temporary interact with the endocytic pathway ([@bib20]). After 1--2 h of infection, *Francisella* escape from the phagosome and multiply within the cytoplasm. The pathogen is recognized by AIM2 when bacterial dsDNA is released into the cytosol upon spontaneous autolysis, as bacterial DNA occasionally colocalizes with AIM2 ([@bib35]; [@bib44]). However, the pathogen uses the lipid/polysaccharide transporter protein, MviN, which is homologous to the *E. coli* putative lipid II flippase, to suppress AIM2 inflammasome activation. Compared with wild-type *F. tularensis,* mice infected with a *F. tularensis mviN* mutant have increased AIM2 inflammasome-dependent IL-1β production and pyroptosis and decreased bacterial burdens ([Fig. 4](#fig4){ref-type="fig"}; [@bib91]). Conversely, infection of *Aim2*^−/−^ mice with *F. tularensis* (as well as *L. monocytogenes* and DNA viruses) results in decreased IL-1β secretion and cell death, and increased mortality and bacterial loads ([@bib35]). These studies validate that the ability of *Francisella* to suppress AIM2 inflammasome is important in enhancing pathogenesis.

We still have a limited understanding of the ability of bacteria to modulate inflammasome activation, and the mechanisms by which bacteria manipulate the inflammasome pathway are still largely speculative ([@bib55]; [@bib89]). Nevertheless, because inflammasome activation as well as caspase-1 activation and subsequent IL-1β secretion and pyroptosis greatly contribute in a variety of protective host responses, we envisage that many other bacterial pathogens use yet-uncharacterized mechanisms to modulate the inflammasome for their benefit.

Conclusion
==========

Bacterial infection elicits a diverse array of host protective and stress responses, including the cell death and proliferative responses, inflammatory response, and innate immune response. The host cell death response critically influences the fate of bacterial infection, the integrity of the host innate defense barrier, innate and acquired immunity, and disease outcome. Bacteria-triggered cell death results in various modes of cell death that greatly vary with the host cell type, stage of infection, infectious dosage, physiological condition of the cell, bacterial factors, and experimental setting. In addition, our understanding of the dynamic interplay between pathogens and host innate defense responses in vitro and in vivo are occasionally contradictory. Nevertheless, as has been described here and in other literature ([@bib55]; [@bib81]), future studies on the cell death response during host--pathogen interactions will provide further insight into the mechanisms by which cells undergo death as an innate defense against microbial infection. Furthermore, a better understanding of the molecular details by which bacterial pathogens manipulate cell death pathways will undoubtedly provide insight into new therapeutic approaches that can be used to control bacterial infection and inflammatory disease progression.
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